Skip to content

Author

L. L. Gluud

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Prevalence of heart failure with preserved ejection fraction (HFpEF) and symptoms in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)

Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with an increased risk of heart failure, particularly heart failure with preserved ejection fraction (HFpEF). The prevalence of HFpEF and related patient-reported functional limitations in MASLD patients with preserved left ventricular...

M. Ramadan, F. S. Davidovski, C. Espersen et al. · 0 citations
Open access Oct 2026

Cardiovascular-kidney-metabolic (CKM) syndrome stage is associated with impaired cardiac structure/function and increased symptom burden in patients with MASLD

Metabolic dysfunction associated steatotic liver disease (MASLD) is closely linked with cardiometabolic risk, but how cardiometabolic burden translates into early cardiac dysfunction in MASLD remains incompletely characterized. We evaluated whether higher cardiovascular-kidney-metabolic (CKM) syndrome stage was a...

A. Stanchev, F. D. Davidovski, C. E. Caroline Espersen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.